The Food and Drug Administration (FDA) in the US approved primary human papillomavirus (HPV) testing for speculum-based cervical cancer screening ten years ago and, in May 2024, approved the self-collection technique. Our study defines the kappa agreement between self- and speculum-based collection techniques for 15 types of high-risk HPV. Additionally, we describe the sensitivity and specificity ratios for HPV testing using both collection methods. Participants recruited in 2020-2022 included 97 colposcopy attendees and 96 routine primary care screening attendees aged 30-65, who agreed to self-sample before their clinically scheduled speculum-based exam. Prevalence-based kappa calculated agreement, sensitivity and specificity ratios calculated accuracy using the cervical intraepithelial neoplasia grade 2 or worse (CIN 2+) threshold. The average ages were 45.9 (SD 10.5) and 46.2 (SD 11.0) years for the colposcopy and primary care attendees, respectively. HPV 16, 68, and 39 were the most common types detected. The lower bound of the 95 % Cl for kappa calculations was above 0.81, indicating almost perfect agreement across all HPV genotypes. The sensitivity and specificity ratios were consistent at 1.0 across both collection methods. The HPV positivity rate was significantly higher among colposcopy attendees at 66 % (64/97), compared to 14 % (13/96) among routine primary care screeners. The study identified 17 women with CIN2 + . Primary HPV screening with self-collection is equivalent to speculum-based collection among people aged 30-65. The findings emphasize the utility of self-collection in identifying high-grade lesions and the consistency of HPV detection across different collection methods.
Urine can provide a non-invasive screening method for high-risk human papillomavirus (hrHPV) infections. We aimed to compare detection rates of hrHPV and cervical intraepithelial neoplasia grade two or worse (CIN2+) using first-void urine (FVU) and clinician-collected cervical samples. We assessed whether the time of day of FVU collection impacts hrHPV detection. We recruited 188 participants, 30–65 years, before their colposcopy or routine screening from September 2020 through February 2022. Each collected FVU twice on the same day: at home and in the clinic before their appointments. We used prevalence-adjusted bias-adjusted kappa (PABAK) scores to compare hrHPV type-specific agreement, followed by McNemar's Exact test. We assessed both absolute and relative sensitivity and specificity to evaluate the accuracy of the collection techniques in predicting CIN2+ by hrHPV type. 95 hrHPV infections were detected in 70/188 (37.2 %) women. The PABAK agreement for hrHPV16 detection between FVU and the speculum was 0.95 (95 % CI: 0.91, 1.0). The agreement for hrHPV detection was almost perfect between home or clinic urine collection and the speculum specimen. The accuracy of CIN2+ detection measured by the sensitivity ratio of the clinic first-void specimen compared to the speculum specimen for hrHPV16 was 1.00 (0.62, 6.20). Most specificity ratios for all other hrHPV types were anchored at 1.0 with narrow confidence intervals. The time of day for FVU gave similar “any hrHPV” detection rates (27.5 % vs 32 %, p > 0.05). FVU hrHPV testing offers a potential cervical cancer screening alternative for women who cannot tolerate other collections.
Objectives: Family physicians care for women across the lifespan, yet little is known about the menopause education they receive during training. We conducted a national survey of US family medicine program directors to characterize the current state of menopause education, including curriculum structure, didactic content, clinical training, and program directors’ perspectives on improvement and standardization. Methods: A cross-sectional survey on menopause education was embedded within the Council of Academic Family Medicine Educational Research Alliance (CERA) omnibus survey, which is administered biannually to family medicine residency program directors and collects standardized program demographic data. Results: Of 313 family medicine program directors who responded to the omnibus survey (44.7% response rate), 279 completed the menopause-specific questions. The majority (94%) reported either a dedicated menopause curriculum or menopause education integrated within a broader women’s health curriculum. Overall 56% of program directors agreed there was a need to improve menopause education; those with an established formal curriculum were less likely to agree (46% vs. 61%, P =0.02), although interest in a standardized national curriculum was similarly high across groups. Conclusions: Menopause education is broadly incorporated across US family medicine residency training, reflecting a meaningful foundation for evidence-based menopause care. However, didactic volume remains limited, content coverage is variable, and training relies heavily on continuity clinic exposure, with little formal assessment. Scalable, on-demand learning modules with competency assessment represent a promising avenue for strengthening menopause training.
23 April 2026 in Archives of Women's Mental Health
Purpose: This study evaluated the efficacy of an online intervention targeting intimate partner violence (IPV) in perinatal women, S trength for U in R elationship E mpowerment (SURE), relative to an attention, time, and information-matched control, on IPV severity, positive affect and well-being, and perceived emotional support across a 12-month follow-up. Methods: Perinatal women ( N = 122) who reported past 12-month IPV and recently engaged in mental health treatment were randomized to SURE ( n = 65) or control ( n = 57). SURE participants received a 40-minute online intervention based in motivational interviewing and empowerment. Control participants viewed a 40-minute online video of popular entertainment, followed by questions about preferences. Both conditions also included a brief 10-15-minute telephone-delivered booster session one month after the online session. Follow-up assessments occurred at 6 weeks, and 3-, 6-, and 12-months since the baseline visit. Results: Both interventions exhibited a significant drop in IPV severity from baseline to 12-month follow-up, with no significant differences between arms (range of standardized effect sizes for the time by group interaction = 0.20–1.65). Significant intervention effects were found for both positive affect and well-being (range of standardized effect sizes for the time by group interaction = -0.04-1.62) and perceived emotional support (range of standardized effect sizes for the time by group interaction = 0.65–2.10), where participants in SURE exhibited significant increases in both outcomes, while control participants did not. Conclusion: Results suggest that SURE provides a good model for an online intervention for perinatal women who have sought mental health services.
30 September 2026 in Archives of Women's Mental Health